Drug Shortage Report for MYLAN-ENALAPRIL

Last updated on 2020-02-20 History
Report ID 54242
Drug Identification Number 02300060
Brand name MYLAN-ENALAPRIL
Common or Proper name ENALAPRIL
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ENALAPRIL SODIUM
Strength(s) 16MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BT, 500 BT
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03
Actual start date 2018-07-03
Estimated end date Unknown
Actual end date 2020-01-23
Shortage status Resolved
Updated date 2020-02-20
Company comments Discontinued in ID 106762. Last lot 8044629-1 exp 2019-12-31
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-02-20 French Compare
v3 2020-02-20 English Compare
v2 2018-07-04 French Compare
v1 2018-07-04 English Compare

Showing 1 to 4 of 4